Citius Oncology CTOR
NASDAQ CTOR
$1.05 +0.02 (+1.94%)
At close: Sep 29, 2026 · 4:00 PM EDT

Citius Oncology (CTOR) Interest Coverage Ratio (2025 - 2026)

Updated

Citius Oncology's (CTOR) Interest Coverage Ratio stood at -37.62 in fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -30.76 a year earlier.

Analysis

Citius Oncology (CTOR) Interest Coverage Ratio (2025 - 2026) Analysis & Trends

On a TTM basis, Citius Oncology's Interest Coverage Ratio came in at -128.56 as of Jun 30, 2026; for FY2025 (ended Sep 30, 2025), it was -107.89.

  • Quarterly Interest Coverage Ratio has ranged from -866.26 in fiscal Q2 2026 to -30.76 in fiscal Q3 2025 over the past five years.
  • Per Business Quant, the preceding three fiscal quarters came in at -866.26 (Q2 2026), -114.58 (Q1 2026) and -82.26 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.41
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 10.28
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 7.27
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 5.22
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -42.08
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Citius Oncology 108.93 Mn 108.93 Mn 1.00 Mn -37.62
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -37.62
Mar 31, 2026 -866.26
Dec 31, 2025 -114.58
Sep 30, 2025 -82.26
Jun 30, 2025 -30.76
API Access

Citius Oncology Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=CTOR&period=max&api_key=YOUR_API_KEY